OT - GERN. Some news. This shows the value of their patents, potential cures, and the amount of funding (and PR exposure) that the industry will be getting over the next few years.
finance.messages.yahoo.com
finance.messages.yahoo.com
finance.messages.yahoo.com
Interesting excerpts:
In fact, everyone is chasing California in the competition for talent, money and recognition.
"There are more dollars now going into the field than there would be if President Bush in 2001 had thrown the gates wide open," said Daniel Perry, the president of the Coalition for the Advancement of Medical Research.
At the very least, competing states are trying to keep their own researchers from joining a migration to the West Coast. At the most, they are cultivating their own biotech valleys, already thriving in ZIP codes around Boston, San Francisco and the Research Triangle in North Carolina, to name a few.
The Illinois legislature is considering a tax on elective cosmetic surgery to raise $100 million a year for stem cell research. In Wisconsin, Gov. Jim Doyle has pledged a $375 million institute for biomedical research, including stem cell projects. Connecticut's governor, M. Jodi Rell, wants to allocate $10 million to $20 million to stem cell research. About 10 other states have similar, if less specific, proposals.
---------------------------
Due to Geron's extensive patents I believe that to a certain extent any money thrown towards the industry helps Geron. If GERN closes above $9 next week I'd get long if you're not already. Telomerase has nothing to do with stem cells FWIW. So it's not like the company is banking entirely upon stem cells. Good info on company web site for those who are interested.
geron.com |
